Tradestie Institutional Equity Comparison Engine
XCH vs BGM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BGM Overall Edge
BGM Captures Institutional Edge (2โ0 Pillars ยท 8โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BGM Group Ltd. Class A Ordinary Shares (BGM) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, XCH trades at N/M Forward P/E with -158.7% operating margin (-17.5% YoY revenue) versus BGM at N/M Forward P/E and -23.4% operating margin (+69.8% YoY). In options structure, XCH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BGM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
XCH N/M vs BGM N/M Fwd P/E
Growth & Margin Winner
BGM
Op Margin -158.7% vs -23.4% ยท YoY -17.5% vs +69.8%
Momentum & Technical Winner
BGM
1Y +131.2% vs -17.5% ยท 52W Pos 44% vs 74%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
XCH
NASDAQ
XCHG Limited American Depositary Share
Power, Distribution & Specialty Transformers
$2.77
-9.9% 1D
Market Cap
$12.3M
1M Return
+33.41%
1Y Return
+131.25%
Forward P/E
N/M
Unified AI Score
41.1 / 100
SELL
Tech 15.0
Fund 33.0
Flow 50.0
Mom 40.0
BGM
NASDAQ
BGM Group Ltd. Class A Ordinary Shares
Pharmaceutical Preparations
$8.00
-1.6% 1D
Market Cap
$108.6M
1M Return
-21.57%
1Y Return
-17.53%
Forward P/E
N/M
Unified AI Score
59.6 / 100
HOLD
Tech 65.0
Fund 55.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
XCH +131.25%
BGM -17.53%
Spread: +166.78 pp (XCH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
XCH TTM Op. Margin: -158.7%
BGM TTM Op. Margin: -23.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XCH vs BGM. Trailing 12-month operating profitability (XCH -158.7% vs BGM -23.4%) and valuation multiples (XCH N/M vs BGM N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | XCH | BGM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.3M | $108.6M | Larger Scale | BGM |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -17.5% | +69.8% | Higher Growth | BGM |
| Operating Margin (TTM) Profitability | -158.7% | -23.4% | Higher Margin | BGM |
| Net Profit Margin Profitability | -158.3% | -44.2% | Higher Margin | BGM |
| Return on Equity (ROE) Capital Efficiency | -204.7% | -7.4% | Higher ROE | BGM |
| 52-Week Range Position Momentum | 44% ($0โ$6) | 74% ($0โ$11) | Stronger Trend | BGM |
| Beta / 30D Volatility Risk Regime | 4.60ฮฒ ยท 254% Vol | 3.69ฮฒ ยท 80% Vol | Lower Realized Risk | BGM |
| Unified Institutional Score Composite Signal | 41.1 / 100 (SELL) | 59.6 / 100 (HOLD) | Higher Composite | BGM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full XCH vs BGM Buy Guide
XCH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BGM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither XCH nor BGM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.